Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 10-16-2023, 08:41 AM   #1
Senior Member
Join Date: Nov 2005
Posts: 524
A Phase I/II Trial of HER2 Vaccine–Primed ...Treatment Refractory HER2–Overexpressing

This is a very hopeful news for Her2 Met patients!

A Phase I/II Trial of HER2 Vaccine–Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2–Overexpressing Breast Cancer


Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets

Nguyen is offline   Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump

All times are GMT -7. The time now is 10:47 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter